A peptide consisting of 7-17 amino acids and including the adjacent hexamer TX 1 EX 2 X 3 E, where X 1 , X 2 and X 3 can be any natural or non natural amino acid, wherein the peptide does not exhibit TNF-receptor-binding activity and is cyclic, for the treatment or prevention of vascular complications in diabetes patients.
